Fairvalue-Calculator Fairvalue-Calculator
EN DE

BRIM Biotechnology, Inc (6885) Fair Value & Analysis

Healthcare · TW · Market cap 3.1B TWD

Price21.35 TWD
Fair Value37.33 TWD
Upside+74.8%
Quality87/100
Evidence: Low Range 27.99 TWD – 46.66 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

BRIM Biotechnology, Inc (6885) currently trades at 21.35 TWD, while our model-based Fair Value estimate is 37.33 TWD — implying the stock looks roughly 74.8% undervalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

BRIM Biotechnology, Inc. engages in the research and development of drugs and therapies to combat and cure diseases in Taiwan. The company's lead product candidate is BRM421, a neurotrophic peptide which has completed a Phase 3 clinical trial for the treatment of dry eye disease. It is also developing BRM424, a treatment option that has completed Phase 1 clinical trial for neurotrophic keratitis; BRM411, a dual target inhibitor, which has completed Phase 2 clinical trial for the treatment of glaucoma; BRM412, an anti-angiogenic eye drop that has completed Phase 2 clinical trial to treat wet age-related macular degeneration; and BRM521, a PEDF-derived short peptide that is in pre-clinical trial to relieve and repair tissue damage caused by osteoarthritis. BRIM Biotechnology, Inc. was founded in 2013 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is BRIM Biotechnology, Inc (6885) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 37.33 TWD versus a price of 21.35 TWD — about +75% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 6885?
Our 21-model fair value for BRIM Biotechnology, Inc is 37.33 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 21.35 TWD.
What is the quality score of 6885?
BRIM Biotechnology, Inc has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.